Levi Garraway MD, PhD
Dr. Levi Garraway, MD, PhD, is an assistant professor of medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute at Harvard Medical School. He is also a senior associate member of the Broad Institute, where he leads several large cancer genome analyses and functional genomics efforts. Garraway leads an investigative team of more than 20 in cancer genomics at Dana-Farber and the Broad Institute. His research has informed several gene targets and pathways that shed light on the genesis and therapeutic vulnerabilities of melanoma, prostate cancer, and other malignancies. Garraway’s group developed OncoMap, a platform for systematic cancer mutation profiling that has inspired multiple personalized cancer medicine efforts across the United States and beyond. Garraway received his AB in biochemical sciences from Harvard College in 1990, and his MD and PhD degrees from Harvard Medical School in 1999. He completed his internship and residency in Internal Medicine at the Massachusetts General Hospital, where he also served as Medical Chief Resident in 2003. He received fellowship training in Medical Oncology at the Dana-Farber Cancer Institute.